NCT05168696 is a NA clinical trial of Virtual Reality Glasses in Breast Cancer Female, sponsored by Necmettin Erbakan University.

Who is sponsoring NCT05168696?

NCT05168696 is sponsored by Necmettin Erbakan University.

What drugs are being tested in NCT05168696?

Interventions in NCT05168696: Virtual Reality Glasses.

What condition does NCT05168696 study?

NCT05168696 studies Breast Cancer Female, Anxiety, Fatigue.

Is NCT05168696 still recruiting?

NCT05168696 is currently completed. Last updated 23 March 2023.

Last reviewed 2023-03-23 · How we verify

NCT05168696

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Virtual Reality on Anxiety and Fatigue in Women With Breast Cancer Receiving Adjuvant Chemotherapy

Completed NA Last updated 23 March 2023

What this trial tests

NA trial testing Virtual Reality Glasses in Breast Cancer Female in 66 participants. Completed in 30 November 2022.

Timeline

4 April 2022

Primary endpoint
30 November 2022

30 November 2022

Quick facts

Lead sponsor	Necmettin Erbakan University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	66
Start date	4 April 2022
Primary completion	30 November 2022
Estimated completion	30 November 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Virtual Reality Glasses

Conditions studied

Breast Cancer Female — all drugs for Breast Cancer Female →
Anxiety — all drugs for Anxiety →
Fatigue — all drugs for Fatigue →

Sponsor

Necmettin Erbakan University

Who can join

Adults 18 to 65, female only, with Breast Cancer Female or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It was aimed to determine the effect of virtual reality glasses application on anxiety and fatigue in women with breast cancer receiving adjuvant chemotherapy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Using Virtual Reality to Improve Outcomes Related to Quality of Life Among Older Adults With Serious Illnesses: Systematic Review of Randomized Controlled Trials.
Maheta B, Kraft A, Interrante N, Fereydooni S, et al · · 2025 · cited 10× · PMID 40009834 · DOI 10.2196/54452

Verify or expand the search:

Other trials of Virtual Reality Glasses

Trials testing the same drug.

NCT07241988 — Virtual Reality and White Noise During Peripheral IV Catheterization in Adults · NA · completed
NCT07066241 — Virtual Reality on Stress, Pain Levels in Patients With Hyperthyroidism Undergoing Biopsy · NA · completed
NCT06964984 — Effects of Virtual Glasses, Stress Ball and Music Intervention on Pain, Anxiety and Comfort in Patients Undergoing Ingui · NA · not yet recruiting
NCT07087990 — Effect of VR Glasses and Stress Ball on Anxiety in Coronary Angiography Patients · NA · completed
NCT06804928 — Effect of Virtual Reality Glasses on Pain, Anxiety, and Comfort During Extracorporeal Shock Wave Lithotripsy · NA · completed

Other recruiting trials for Breast Cancer Female

Currently open trials in the same condition.

NCT07505797 — ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) · recruiting
NCT07198724 — ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrin · Phase 1, PHASE2 · recruiting
NCT07331506 — Validation of the Oncoliq Test for the Early Detection of Breast Cancer. · recruiting
NCT07214883 — UCF MammoChat: Image Repository · recruiting
NCT07120100 — Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Surviv · NA · recruiting

Other Necmettin Erbakan University trials

Trials by the same sponsor.

NCT07128407 — PMT-Based Radiation Safety Training for Nurses: Randomized Controlled Trial. · NA · active not recruiting
NCT07504770 — Surgical Glove Compression to Prevent Paclitaxel Neuropathy · NA · not yet recruiting
NCT07242807 — Minimally Invasive Prostate Interventions Registry (MIST Study) · not yet recruiting
NCT07442331 — The Effect of Game-Based Learning on Identifying Cognitive Distortions and Interpersonal Communication Competence in Nur · NA · completed
NCT07396038 — INTRAOPERATIVE BLADDER INJURY ASSESSMENT IN TURBT USING BICEP · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05168696 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Necmettin Erbakan University
Last refreshed: 23 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05168696.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing